Studenik C, Lemmens-Gruber R, Heistracher P, Ecker G, Maxl A, Fleischhacker W
Institut für Pharmakologie und Toxikologie, Pharmaziezentrum, Vienna, Austria.
Arzneimittelforschung. 1996 Feb;46(2):134-8.
Inotropic, chronotropic and beta-adrenoceptor blocking activities of the newly synthetized propafenone derivatives 1-(2-(3-diethylamino-2-hydroxypropoxy)phenyl-3-phenyl-1-propanone hydrochloride (AM 03), 1-(2-(2-hydroxy-3-(1-piperidyl)propoxy)phenyl)-3-phenyl-1-propanone hydrochloride (AM 05), N,N-dimethyl-N-(2-hydroxy-3-(2-(3- phenylpropionyl)phenoxy)propyl)-propylammonium iodide (TH 41), N,N- diethyl-N-(2-hydroxy-3-(2-(3-phenylpropionyl)phenoxy)propyl)-methylammon ium iodide (AM 07), and N,N-diiso-propyl-N-(2-hydroxy-3-(2-(3-phenylpropionyl)phenoxy)prop yl)- methylammonium iodide (AM 09) studied in isolated, electrically stimulated papillary muscles and spontaneously beating right atria of guinea pigs. In comparison with propafenone the tertiary amines AM 03 and AM 05 showed a higher negative inotropic potency, while the quarternary amines TH 41, AM 07 and AM 09 were less effective. With regard to their negative chronotropic action, AM 03 and AM 05 were more and TH 41, AM 07 and AM 09 less potent than the parent drug. In contrast to propafenone none of its derivatives exerted beta-adrenoceptor blockade at the concentrations studied.
在豚鼠离体电刺激乳头肌和自发搏动右心房中研究了新合成的普罗帕酮衍生物1-(2-(3-二乙氨基-2-羟基丙氧基)苯基)-3-苯基-1-丙酮盐酸盐(AM 03)、1-(2-(2-羟基-3-(1-哌啶基)丙氧基)苯基)-3-苯基-1-丙酮盐酸盐(AM 05)、N,N-二甲基-N-(2-羟基-3-(2-(3-苯丙酰基)苯氧基)丙基)-丙基碘化铵(TH 41)、N,N-二乙基-N-(2-羟基-3-(2-(3-苯丙酰基)苯氧基)丙基)-甲基碘化铵(AM 07)和N,N-二异丙基-N-(2-羟基-3-(2-(3-苯丙酰基)苯氧基)丙基)-甲基碘化铵(AM 09)的变力性、变时性和β-肾上腺素能受体阻断活性。与普罗帕酮相比,叔胺AM 03和AM 05显示出更高的负性变力效能,而季胺TH 41、AM 07和AM 09的效能较低。就其负性变时作用而言,AM 03和AM 05比母体药物更强,而TH 41、AM 07和AM 09则较弱。与普罗帕酮不同,在所研究的浓度下,其衍生物均未表现出β-肾上腺素能受体阻断作用。